Hormonally Related Headaches

Nappi, Rossella E.; Martella, Silvia; Sances, Grazia; Piccinino, Manuela; Rossini, Roberta; Tiranini, Lara; Brambilla, Emanuela; Franco, Alessandro; Inzoli, Alessandra; Tassorelli, Cristina

doi:10.1007/978-3-030-14358-9_8

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Unclassified

Year Published

2022

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 46 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Анализ назначения КОК при мигрени с аурой (МА) продемонстрировал ухудшение симптомов в большей степени (56,4%), нежели при мигрени без ауры (МбА; 25,3%). Более того, женщины могли отмечать появление ауры во время инициации терапии КОК [10].…”

unclassified

Hormone therapy for menstrual-associated migraine: pros and cons

Kiryanova

Tabeeva

2022

RJTAO

View full text Add to dashboard Cite

About 60% of women report menstrual-associated migraine attacks, characterized by a higher intensity and duration and more pronounced treatment resistance. Often, preventive treatment with drugs aimed to relieve menstrual attacks – non-steroidal anti-inflammatory drugs and triptans – is difficult in these patients due to a high risk of medication-overuse headache. In addition, due to a hormonal trigger – a perimenstrual decrease in estrogen – the effect of hormonal contraceptives on migraine attacks has been studied for a long time. This article discusses the results of studies indicating the successful administration of specific hormone therapy regimens, especially in patients with concomitant gynecological pathology or in patients using these drugs for contraception.

show abstract

unclassified